APA

Sveikata A., Liutkauskienė S., Juozaitytė E., Characiejus D., Tamošaitytė L. & Šeštakauskas K. (20120224). An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. : Medicina (Kaunas, Lithuania).

Chicago

Sveikata Audrius, Liutkauskienė Sigita, Juozaitytė Elona, Characiejus Dainius, Tamošaitytė Laimutė and Šeštakauskas Kastytis. 20120224. An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. : Medicina (Kaunas, Lithuania).

Harvard

Sveikata A., Liutkauskienė S., Juozaitytė E., Characiejus D., Tamošaitytė L. and Šeštakauskas K. (20120224). An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. : Medicina (Kaunas, Lithuania).

MLA

Sveikata Audrius, Liutkauskienė Sigita, Juozaitytė Elona, Characiejus Dainius, Tamošaitytė Laimutė and Šeštakauskas Kastytis. An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients. : Medicina (Kaunas, Lithuania). 20120224.